Bacterial growth inhibition by amniotic fluid. VIII. Evaluation of a radiometric bioassay for rapid, in vitro demonstration of phosphate-sensitive bacterial growth inhibitor in amniotic fluid.
A radiometric bioassay based on the continuous monitoring of 14CO2 released from labeled glucose in the presence of amniotic fluid or amniotic fluid with added phosphate has been employed to detect the presence of a phosphate-sensitive bacterial inhibitor in amniotic fluid near term. The time required for detection of the inhibitory activity is approximately 12 hours, in contrast to approximately 36 hours required for a previously reported technique. Application of this radiometric bioassay to demonstrate bacterial growth inhibition by amniotic fluid and physicochemical properties of the inhibitory activity yielded results comparable to those obtained with the older method of plate counts of viable bacteria. By the new technique it was possible to demonstrate that the inhibitory activity was phosephate sensitive, heat stable, inactivated by metal chelation, removed by bentonite, and present in a low-molecular-weight fraction of amniotic fluid.
D000653:Amniotic Fluid / Q000502:physiology*; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development*; D001546:Bentonite; D001681:Biological Assay; D003114:Colony-Forming Units Assay; D004230:Dithizone; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D005260:Female; D006131:Growth Inhibitors / Q000494:pharmacology; D006358:Hot Temperature; D006801:Humans; D010710:Phosphates / Q000494:pharmacology; D011247:Pregnancy; D011874:Radiometry
D006131:Growth Inhibitors; D010710:Phosphates; D001546:Bentonite; D004230:Dithizone